O. Ström

4.8k total citations · 2 hit papers
68 papers, 3.4k citations indexed

About

O. Ström is a scholar working on Orthopedics and Sports Medicine, Surgery and Oncology. According to data from OpenAlex, O. Ström has authored 68 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Orthopedics and Sports Medicine, 25 papers in Surgery and 19 papers in Oncology. Recurrent topics in O. Ström's work include Bone health and osteoporosis research (38 papers), Hip and Femur Fractures (20 papers) and Bone health and treatments (17 papers). O. Ström is often cited by papers focused on Bone health and osteoporosis research (38 papers), Hip and Femur Fractures (20 papers) and Bone health and treatments (17 papers). O. Ström collaborates with scholars based in Sweden, United Kingdom and United States. O. Ström's co-authors include John А. Kanis, Eugène McCloskey, F. Borgström, Fredrik Borgström, Anders Odén, Bengt Jönsson, Helena Johansson, Cyrus Cooper, J. A. Kanis and H Johansson and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

O. Ström

63 papers receiving 3.3k citations

Hit Papers

FRAX® and its applications to clinical practice 2009 2026 2014 2020 2009 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Ström Sweden 25 2.4k 1.6k 966 648 414 68 3.4k
B. Jönsson Sweden 8 1.6k 0.7× 1.2k 0.7× 481 0.5× 537 0.8× 281 0.7× 14 2.7k
E. V. McCloskey United Kingdom 16 2.1k 0.9× 1.4k 0.9× 1.1k 1.1× 775 1.2× 442 1.1× 19 3.8k
J. Compston United Kingdom 13 2.3k 0.9× 1.5k 0.9× 686 0.7× 709 1.1× 409 1.0× 23 3.5k
H Johansson Sweden 27 2.8k 1.1× 2.5k 1.5× 854 0.9× 672 1.0× 256 0.6× 63 4.5k
Wojciech P. Olszynski Canada 30 3.1k 1.3× 1.4k 0.8× 1.4k 1.5× 954 1.5× 429 1.0× 68 4.5k
M Ivergård Sweden 6 1.7k 0.7× 1.2k 0.7× 496 0.5× 554 0.9× 280 0.7× 26 2.7k
Alkım Öden Akman Türkiye 15 2.2k 0.9× 1.3k 0.8× 702 0.7× 537 0.8× 289 0.7× 46 2.9k
A Tosteson United States 8 2.0k 0.8× 967 0.6× 663 0.7× 514 0.8× 377 0.9× 10 2.7k
A Svedbom United Kingdom 5 1.6k 0.7× 1.2k 0.8× 472 0.5× 529 0.8× 330 0.8× 21 2.6k
Peyman Hadji Germany 32 2.0k 0.8× 619 0.4× 1.4k 1.4× 748 1.2× 321 0.8× 120 3.0k

Countries citing papers authored by O. Ström

Since Specialization
Citations

This map shows the geographic impact of O. Ström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Ström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Ström more than expected).

Fields of papers citing papers by O. Ström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Ström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Ström. The network helps show where O. Ström may publish in the future.

Co-authorship network of co-authors of O. Ström

This figure shows the co-authorship network connecting the top 25 collaborators of O. Ström. A scholar is included among the top collaborators of O. Ström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Ström. O. Ström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukacova, Slávka, et al.. (2025). Evaluating work activity and societal burden in patients with grade 2 IDH-mutant glioma. Neuro-Oncology Practice.
4.
Kanis, John А., et al.. (2021). Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden. Osteoporosis International. 32(3). 585–594. 24 indexed citations
5.
Borgström, F., O. Ström, Cesar Libanati, et al.. (2021). A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis. Osteoporosis International. 32(7). 1301–1311. 11 indexed citations
6.
Banefelt, Jonas, Kristina Åkesson, Östen Ljunggren, et al.. (2017). Short-Term Fracture (Fx) Incidence And Risk Factors Following Fracture In A Swedish Database Study. Osteoporosis International. 28. 1 indexed citations
7.
Ortsäter, Gustaf, O. Ström, & Achim Kautz. (2016). The Economic Burden of Hepatitis C In France And Romania. Value in Health. 19(7). A582–A582. 1 indexed citations
8.
Ström, O., Erik Landfeldt, & Göran Garellick. (2014). Residual effect after oral bisphosphonate treatment and healthy adherer effects—the Swedish adherence register analysis (SARA). Osteoporosis International. 26(1). 315–325. 15 indexed citations
9.
Jonsson, E, et al.. (2014). Systematic Review and Meta-Analysis of Persistence With Denosumab in Patients With Osteoporosis. Value in Health. 17(7). A383–A384. 3 indexed citations
10.
Karlsson, Linda, et al.. (2013). Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal Osteoporosis. Value in Health. 16(7). A567–A567. 4 indexed citations
11.
Borgström, Fredrik, Gylfi Ólafsson, O. Ström, et al.. (2013). The impact of different health dimensions on overall quality of life related to kyphoplasty and non-surgical management. Osteoporosis International. 24(7). 1991–1999. 15 indexed citations
12.
Johansson, Helena, et al.. (2011). 10-årsrisken för fraktur. Stöd i behandlingen av osteoporos, enligt preliminära svenska riktlinjer.. Läkartidningen. 108(7). 336–339. 2 indexed citations
13.
Ström, O., F. Borgström, John А. Kanis, et al.. (2011). Osteoporosis: burden, health care provision and opportunities in the EU. Archives of Osteoporosis. 6(1-2). 59–155. 435 indexed citations breakdown →
14.
Rolfson, Ola, O. Ström, Johan Kärrholm, Henrik Malchau, & Göran Garellick. (2011). Costs Related to Hip Disease in Patients Eligible for Total Hip Arthroplasty. The Journal of Arthroplasty. 27(7). 1261–1266. 19 indexed citations
15.
Landfeldt, Erik, Jonas Lundkvist, & O. Ström. (2010). The societal burden of poor persistence to treatment of osteoporosis in Sweden. Bone. 48(2). 380–388. 19 indexed citations
16.
Borgström, Fredrik, O. Ström, E. V. McCloskey, et al.. (2010). Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective. Osteoporosis International. 22(3). 955–965. 24 indexed citations
17.
Lekander, Ingrid, Fredrik Borgström, O. Ström, Niklas Zethraeus, & John А. Kanis. (2009). Cost-effectiveness of hormone replacement therapy for menopausal symptoms in the UK. Menopause international. 15(1). 19–25. 10 indexed citations
18.
Lekander, Ingrid, Fredrik Borgström, O. Ström, Niklas Zethraeus, & John А. Kanis. (2009). Cost-Effectiveness of Hormone Therapy in the United States. Journal of Women s Health. 18(10). 1669–1677. 20 indexed citations
19.
Ström, O., F. Borgström, John А. Kanis, & Bengt Jönsson. (2008). Incorporating adherence into health economic modelling of osteoporosis. Osteoporosis International. 20(1). 23–34. 62 indexed citations
20.
Sobocki, Patrik, Ingrid Lekander, Fredrik Borgström, O. Ström, & Bo Runeson. (2006). The economic burden of depression in Sweden from 1997 to 2005. European Psychiatry. 22(3). 146–152. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026